Star Imaging and Path Lab Limited (BOM:544482)
India · Delayed Price · Currency is INR 93.88
+1.88 (2.04%)
At close: Aug 21, 2026
Star Imaging and Path Lab Revenue
In the fiscal year ending March 31, 2026, Star Imaging and Path Lab had annual revenue of 885.27M INR with 6.02% growth. Star Imaging and Path Lab had revenue of 433.36M in the half year ending March 31, 2026.
Revenue
885.27M
Revenue Growth
+6.02%
P/S Ratio
1.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.64B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 885.27M | 50.27M | 6.02% |
| Mar 31, 2025 | 835.00M | 47.16M | 5.99% |
| Mar 31, 2024 | 787.84M | 202.52M | 34.60% |
| Mar 31, 2023 | 585.32M | -105.53M | -15.28% |
| Mar 31, 2022 | 690.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Modern Diagnostic & Research Centre | 841.37M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |